Clinical usefulness of the WHO histological classification of thymoma.
OBJECTIVE
Rosai et al. published the World Health Organization (WHO) classification of thymic epithelial tumors in 1999, and its clinical usefulness seems to be established. It is our purpose to find the clinically relevant diagnostic points in the WHO Histological Classification of Thymoma.


METHODS
Thymomas surgically removed from 100 consecutive patients at Juntendo University Hospital between October 1983 and February 2002 were classified according to the WHO histological classification. We assessed overall survival and recurrence-free rate calculated for each tumor type in the WHO classification compared with those of tumors classified by the Masaoka system.


RESULTS
The thymic epithelial tumors in this series comprised 10 type A, 15 type AB, 18 type B1, 21 type B2, 33 type B3, and 3 type C tumors according to the WHO classification. Based on the Masaoka system, the disease was stage I in 53 patients, stage II in 30, stage III in 15, and stage IV in 2. The 15-year recurrence-free rate was 100% for type A, AB and B1, while the rates for types B2 and B3 were 66.7% and 54.5%, respectively. The 10-year recurrence-free rate was 66.7% for type C. The 15-year recurrence-free rate of the 64 patients with type A, AB, B1, and B2 thymomas was significantly higher from that of the 33 patients with type B3 thymoma (p=0.0026).


CONCLUSIONS
When using the WHO classification, it is critical to distinguish type B3 thymoma from other tumor types.
Sonobe
Satoshi
S
Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, and Department of Clinical Laboratory, Labor Welfare Corporation Kanto Rosai Hospital, Kanagawa, Japan.
Miyamoto
Hideaki
H
Izumi
Hiroshi
H
Nobukawa
Bunsei
B
Futagawa
Toshiro
T
Yamazaki
Akio
A
Oh
Tumin
T
Uekusa
Toshimasa
T
Abe
Hiroshi
H
Suda
Koichi
K
D000328:Adult; D000368:Aged; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013945:Thymoma / Q000145:classification* / Q000401:mortality / Q000473:pathology*; D013953:Thymus Neoplasms / Q000145:classification* / Q000401:mortality / Q000473:pathology*; D014944:World Health Organization